Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
boston blog main
3
×
life sciences
boston
boston top stories
national blog main
national top stories
postpartum depression
sage therapeutics
acc
acquisition
activist investor
aducanumab
alzheimer's failure
american college of cardiology
amyloid
andreas grauer
apple watch
atrial fibrillation
biohaven
bioinnovation capital
biolabs
black box
black box warning
boulder/denver blog main
boulder/denver top stories
brexanalone
brexanolone
bristol-myers squibb
broad institute
celgene
chemotherapy
clinical data
corcept pharmaceuticals
crispr diagnostic
cydan
daraprim
depression
detroit blog main
detroit top stories
What
drug
3
×
medical
3
×
depression
good
postpartum
sage
adu
approval
approved
beats
bids
bio
biogen
biotech
brexanalone
complicated
dire
driving
fda
group
healthcare
heart
help
history
hits
hour
improved
industry
infusion
innovation
innovations
investment
life
long
mark
need
news
outcomes
people
phase
Language
unset
Current search:
drug
×
biotech
×
medical
×
" boston blog main "
×
@xconomy.com
4 years ago
Drug Pricing: Innovation, Investment, and the Public Good
@xconomy.com
5 years ago
Bio Roundup: Sage Postpartum Help, Biogen Bids Adu, Heart Beats & More
@xconomy.com
5 years ago
Sage Hits Mark in Postpartum Depression Phase 3 Trial, Stock Surges
